These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2337880)

  • 1. Shapes of benz[a]anthracenes: the crystal and molecular structure of 6-methylbenz[a]anthracene.
    Jones DW; Shaw JD
    Cancer Biochem Biophys; 1990 Jan; 11(1):1-6. PubMed ID: 2337880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shapes of benz[a]anthracenes: the crystal and molecular structure of 2-methylbenz[a]anthracene.
    Briant CE; Jones DW
    Cancer Biochem Biophys; 1985 Dec; 8(2):129-35. PubMed ID: 3841296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shapes of carcinogenic benz[alpha]anthracenes: an x-ray crystal structure analysis of 12-methylbenz[alpha]anthracene.
    Jones DW; Sowden JM
    Cancer Biochem Biophys; 1976; 1(6):281-8. PubMed ID: 1016936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shapes of carcinogenic benz[a]anthracenes: the crystal and molecular structure of 1-methylbenz[a]anthracene.
    Jones DW; Sowden JM
    Cancer Biochem Biophys; 1979; 4(1):43-7. PubMed ID: 498062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular structure of 11-methylbenz[a]anthracene: an almost planar substituted benz[a]anthracene.
    Briant CE; Jones DW
    Carcinogenesis; 1984 Mar; 5(3):363-5. PubMed ID: 6705141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.
    Wood AW; Levin W; Chang RL; Conney AH; Slaga TJ; O'Malley RF; Newman MS; Buhler DR; Jerina DM
    J Natl Cancer Inst; 1982 Sep; 69(3):725-8. PubMed ID: 6810009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of a carcinogen:nucleoside adduct.
    Carrell HL; Glusker JP; Moschel RC; Hudgins WR; Dipple A
    Cancer Res; 1981 Jun; 41(6):2230-4. PubMed ID: 6786734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular structures of the chemical carcinogens 7-chloromethylbenz(a)anthracene and 7-chloromethyl-12-methylbenz(a)anthracene.
    Glusker JP; Zacharias DE; Carrell HL
    Cancer Res; 1976 Jul; 36(7 PT 1):2428-35. PubMed ID: 1277150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of the trans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz(a)anthracene and other benz(a)anthracene derivatives by 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase: effects of methyl substitution on velocity and stereochemical course of trans-dihydrodiol oxidation.
    Smithgall TE; Harvey RG; Penning TM
    Cancer Res; 1988 Mar; 48(5):1227-32. PubMed ID: 3124956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular structure of the K-region cis-dihydrodiol of 7,12-dimethylbenz[a]anthracene.
    Zacharias DE; Glusker JP; Harvey RG; Fu PP
    Cancer Res; 1977 Mar; 37(3):775-82. PubMed ID: 402208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray refinement of the crystal and molecular structure of 1,12-dimethylbenz[a]anthracene.
    Jones DW; Shaw JD
    Carcinogenesis; 1987 Sep; 8(9):1323-6. PubMed ID: 3113756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular structure of benzo(a)pyrene 4,5-oxide.
    Glusker JP; Zacharias DE; Carrell HL; Fu PP; Harvey RG
    Cancer Res; 1976 Nov; 36(11 Pt 1):3951-7. PubMed ID: 975043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steric strain and tumorigenicity: the molecular structure of 3,6-dimethylcholanthrene.
    Jones DW; Shaw JD
    Carcinogenesis; 1989 Oct; 10(10):1829-31. PubMed ID: 2791201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of a coumarin derivative related to the carcinogen benz[a]anthracene.
    Flocco MM; Carrell HL; Harvey RG; Zacharias DE; Glusker JP
    Carcinogenesis; 1996 Oct; 17(10):2245-8. PubMed ID: 8895495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakdown products on metabolic pathway of degradation of benz[a]anthracene by a ligninolytic fungus.
    Cajthaml T; Erbanová P; Sasek V; Moeder M
    Chemosphere; 2006 Jul; 64(4):560-4. PubMed ID: 16403417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituent effects in benz[a]anthracene carbocations: a stable ion, electrophilic substitution (nitration, bromination), and DFT study.
    Laali KK; Arrica MA; Okazaki T; Harvey RG
    J Org Chem; 2007 Aug; 72(18):6768-75. PubMed ID: 17676909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-Chloromethyl-12-methylbenz(a)anthracene.
    Carrell HL
    Acta Crystallogr C; 1993 May; 49 ( Pt 5)():902-5. PubMed ID: 8347306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercalation of the (-)-(1R,2S,3R, 4S)-N6-[1-benz[a]anthracenyl]-2'-deoxyadenosyl adduct in an oligodeoxynucleotide containing the human N-ras codon 61 sequence.
    Li Z; Mao H; Kim HY; Tamura PJ; Harris CM; Harris TM; Stone MP
    Biochemistry; 1999 Mar; 38(10):2969-81. PubMed ID: 10074349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the products of the reaction of 7-methylbenz(a)anthracene 5,6-oxide and RNA, with those formed in 7-methylbenz(a)anthracene-treated cells.
    Baird WM; Grover PL; Sims P; Brookes P
    Cancer Res; 1976 Jul; 36(7 PT 1):2306-11. PubMed ID: 1277134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.